Trial Profile
ZELBORAF Special Drug Use Surveillance (Malignant Melanoma)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Jan 2022
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 28 Feb 2015 New trial record